ENDOMETRIAL DYSPLASIA

ENDOMETRIAL DYSPLASIA was reported 25 times

ENDOMETRIAL DYSPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TOREMIFENE CITRATE 1 0.0023
1 CALCIUM FOLINATE 1 0.0002
2 TAMOXIFEN CITRATE 1 0.0002
3 IFOSFAMIDE FOR INJECTION 3 0.0001
4 CLADRIBINE 1 0.0001
5 DIPHENHYDRAMINE HCL 1 0.0001
6 GOSERELIN 1 0.0001
7 EVEROLIMUS TABLETS 1 0.0001
8 OXALIPLATIN 4 0.0001
9 PRAVASTATIN SODIUM 1 0.0000
10 ETOPOSIDE 3 0.0000
11 FLUOROURACIL CREAM, 0.5% 3 0.0000
12 FLUOROURACIL 3 0.0000
13 CAPECITABINE 3 0.0000
14 BELIMUMAB 1 0.0000
15 LEVONORGESTREL 5 0.0000
16 COPPER 1 0.0000
17 DROSPIRENONE AND ETHINYL ESTRADIOL 1 0.0000
18 ESTRADIOL TRANSDERMAL 1 0.0000
19 EVEROLIMUS 1 0.0000
20 PACLITAXEL 2 0.0000
21 CONJUGATED ESTROGENS 1 0.0000
22 ESTROGENS, CONJUGATED 1 0.0000
23 LAMOTRIGINE 2 0.0000
24 LAMOTIRIGINE 1 0.0000
25 LAMOTRIGINE CHEWABLE DISPERSIBLE 1 0.0000
26 ESTRADIOL 1 0.0000
27 LEVOTHYROXINE SODIUM ANHYDROUS 1 0.0000
28 FAMOTIDINE 1 0.0000
29 CELECOXIB 1 0.0000
30 TACROLIMUS 1 0.0000
31 CLONAZEPAM 1 0.0000
32 DIPHENHYDRAMINE HYDROCHLORIDE 1 0.0000
33 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
34 CYCLOPHOSPHAMIDE 1 0.0000
35 NATALIZUMAB 1 0.0000
36 ATORVASTATIN CALCIUM 1 0.0000
37 DEXAMETHASONE 1.5 MG 1 0.0000
38 DEXAMETHASONE 1 0.0000
39 LEVOTHYROXINE SODIUM 1 0.0000
40 GABAPENTIN 1 0.0000
41 ETANERCEPT 1 0.0000
42 ADALIMUMAB 1 0.0000